The global High-intensity Focused Ultrasound (HIFU) therapy market is expected to rise at a considerable rate in the coming years. The use of ultrasound waves in high-intensity focused ultrasound therapy (HIFU) is a new and growing therapeutic method. Tumor ablation, thrombolysis, hemostasis, and targeted drug/gene delivery are all possible with HIFU. Cancer therapy is a significant concern in both developed and developing countries. Ultrasound has been utilized not only to diagnose cancer but also to treat it. Focused ultrasonic surgery (FUS) is a non-invasive procedure that, when utilized in conjunction with high-intensity imaging, can accurately ablate malignant lesions. Mechanical and thermal effects are involved in HIFU ablation mechanisms. The popularity of HIFU has grown as a result of recent improvements. Many encouraging results have been produced in the treatment of prostate, pancreas, breast, liver, kidney, and bone cancers.
Increased cancer prevalence, increased public knowledge of the therapy, approval of HIFU therapy for additional purposes, and improved treatment safety and success are all major factors driving the HIFU therapy market. According to the World Health Organization (WHO), Cancer is the second leading cause of death globally, accounting for an estimated 9.6 million deaths, or one in six deaths, in 2018. Lung, prostate, colorectal, stomach, and liver cancer are the most common types of cancer in men, while breast, colorectal, lung, cervical, and thyroid cancer are the most common among women. An increase in the occurrence of cancer is predictable to boost the growth of the HIFU therapy market during the forecast period.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Application, End-User, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | EDAP TMS, THERACLION, CARDIAWAVE, BrainSonix Corporation, FUS Instruments, Image Guided Therapy, Promedica Bioelectronics s.r.l., Verasonics, Inc., PROFOUND MEDICAL Corp., EpiSonica. |
Covid-19 Impact on High-intensity Focused Ultrasound (HIFU) Therapy Market
In addition, the current High-intensity Focused Ultrasound (HIFU) Therapy market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the High-intensity Focused Ultrasound (HIFU) Therapy market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
High-intensity Focused Ultrasound (HIFU) Therapy Market Segment Overview
Based on Application, Hemostasis is one of the important segments in the High-intensity Focused Ultrasound (HIFU) therapy market. Hemostasis or haemostasis is a process to prevent and stop bleeding, meaning to keep blood within a damaged blood vessel (the opposite of hemostasis is hemorrhage). It is the first stage of wound healing. This includes coagulation, blood changing from a liquid to a gel. Furthermore, Thrombolysis is another major segment in the market. Thrombolysis, also known as thrombolytic therapy, is a treatment to dissolve dangerous clots in blood vessels, improve blood flow, and prevent damage to tissues and organs.
High-intensity Focused Ultrasound (HIFU) Therapy Market, By Application
· Hemostasis
· Thrombolysis
· Target Drug Delivery
· Tumor Ablation
· Others
High-intensity Focused Ultrasound (HIFU) Therapy Market, By End-User
· Hospitals
· Diagnostic Centers
· Research Centers
High-intensity Focused Ultrasound (HIFU) Therapy Market Regional Overview
Region-wise, North America commanded a major share of the High-intensity Focused Ultrasound (HIFU) Therapymarket and is predictable to maintain its supremacy over the forecast period. The significant market share of North America is mainly attributed to the high diagnosis rate of diseases, high disposable income, well-developed health care infrastructure, and good awareness about the latest medical developments among people. Besides, increasing research and development activities in the region promoting the development of new therapies can be attributed to the huge market share of the region. Moreover, the market in the Asia Pacific is anticipated to boost at a rapid rate, owing to the rise in the occurrence of cancer, investment by market players in developing countries such as China and India, and increased consumer awareness about the treatment of cancer. Further, the Middle East & Africa, and Latin America, are expected to be major regions of the markets in the coming years. This is because of the high adoption rate of advanced therapeutics and a speedily developing health care industry.
High-intensity Focused Ultrasound (HIFU) Therapy Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
High-intensity Focused Ultrasound (HIFU) Therapy Market, Key Players
· EDAP TMS
· THERACLION
· CARDIAWAVE
· BrainSonix Corporation
· FUS Instruments
· Image Guided Therapy
· Promedica Bioelectronics s.r.l.
· Verasonics, Inc.
· PROFOUND MEDICAL Corp.
· EpiSonica
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the High-intensity Focused Ultrasound (HIFU) Therapy market?
Q2. Which Segments are covered in the High-intensity Focused Ultrasound (HIFU) Therapy Market report?
Q3. Which segment is projected to hold the largest share in the High-intensity Focused Ultrasound (HIFU) Therapy market. ?
Q4. Which region holds the largest share in the High-intensity Focused Ultrasound (HIFU) therapy market?
Q5. Which are the prominent players in the High-intensity Focused Ultrasound (HIFU) Therapy Market?
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global High-intensity Focused Ultrasound (HIFU) Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Application
- 5.2.1. Hemostasis
- 5.2.2. Thrombolysis
- 5.2.3. Target Drug Delivery
- 5.2.4. Tumor Ablation
- 5.2.5. Others
- 5.3. Market Analysis, Insights and Forecast – By End-User
- 5.3.1. Hospitals
- 5.3.2. Diagnostic Centers
- 5.3.3. Research Centers
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Latin America, Middle East and Africa
6. North America High-intensity Focused Ultrasound (HIFU) Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Application
- 6.2.1. Hemostasis
- 6.2.2. Thrombolysis
- 6.2.3. Target Drug Delivery
- 6.2.4. Tumor Ablation
- 6.2.5. Others
- 6.3. Market Analysis, Insights and Forecast – By End-User
- 6.3.1. Hospitals
- 6.3.2. Diagnostic Centers
- 6.3.3. Research Centers
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
7. Europe High-intensity Focused Ultrasound (HIFU) Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Application
- 7.2.1. Hemostasis
- 7.2.2. Thrombolysis
- 7.2.3. Target Drug Delivery
- 7.2.4. Tumor Ablation
- 7.2.5. Others
- 7.3. Market Analysis, Insights and Forecast – By End-User
- 7.3.1. Hospitals
- 7.3.2. Diagnostic Centers
- 7.3.3. Research Centers
- 7.4. Market Analysis, Insights and Forecast – By Country
- 7.4.1. UK
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Italy
- 7.4.5. Spain
- 7.4.6. Russia
- 7.4.7. Rest of Europe
8. Asia Pacific High-intensity Focused Ultrasound (HIFU) Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Application
- 8.2.1. Hemostasis
- 8.2.2. Thrombolysis
- 8.2.3. Target Drug Delivery
- 8.2.4. Tumor Ablation
- 8.2.5. Others
- 8.3. Market Analysis, Insights and Forecast – By End-User
- 8.3.1. Hospitals
- 8.3.2. Diagnostic Centers
- 8.3.3. Research Centers
- 8.4. Market Analysis, Insights and Forecast – By Country
- 8.4.1. China
- 8.4.2. India
- 8.4.3. Japan
- 8.4.4. Australia
- 8.4.5. South East Asia
- 8.4.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa High-intensity Focused Ultrasound (HIFU) Therapy Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Application
- 9.2.1. Hemostasis
- 9.2.2. Thrombolysis
- 9.2.3. Target Drug Delivery
- 9.2.4. Tumor Ablation
- 9.2.5. Others
- 9.3. Market Analysis, Insights and Forecast – By End-User
- 9.3.1. Hospitals
- 9.3.2. Diagnostic Centers
- 9.3.3. Research Centers
- 9.4. Market Analysis, Insights and Forecast – By Country
- 9.4.1. Brazil
- 9.4.2. Saudi Arabia
- 9.4.3. UAE
- 9.4.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. EDAP TMS
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. THERACLION
- 10.6. CARDIAWAVE
- 10.7. BrainSonix Corporation
- 10.8. FUS Instruments
- 10.9. Image Guided Therapy
- 10.10. Promedica Bioelectronics s.r.l.
- 10.11. Verasonics, Inc.
- 10.12. PROFOUND MEDICAL Corp.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
